Journal
/
Immunology and Infection
/
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
JoVE Journal
Immunology and Infection
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Immunology and Infection
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

English

Automatically Generated

13,483 Views

•

11:34 min

•

May 05, 2014

DOI:

10.3791/51222-v

DOI:
10.3791/51222-v

•

11:34 min
May 05, 2014

•

6 Views
, , , , , ,
1Unité de Génomique Virale et Vaccination, Virology Department,Institut Pasteur, CNRS UMR3569, 2Unité de Chimie et Biocatalyse, Biochemistry and Structural Biology Department,Institut Pasteur, CNRS UMR3523, 3Unité des Interactions Moléculaires Flavivirus-Hôtes, Virology Department,Institut Pasteur

Summary

Automatically generated

In vitro assays to measure virus replication have been greatly improved by the development of recombinant RNA viruses expressing luciferase or other enzymes capable of bioluminescence. Here we detail a high-throughput screening pipeline that combines such recombinant strains of measles and chikungunya viruses to isolate broad-spectrum antivirals from chemical libraries.

Explore More Videos

High-throughput ScreeningBroad-spectrum Chemical InhibitorsRNA VirusesCellular PathwaysHost Cell FunctionsAntiviral CompoundsRecombinant VirusesReporter EnzymesBioluminescenceLuciferaseMeasles VirusChikungunya VirusCell Culture Assays

Read Article

Cite this Article

Lucas-Hourani, M., Munier-Lehmann, H., Helynck, O., Komarova, A., Desprès, P., Tangy, F., Vidalain, P. High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses. J. Vis. Exp. (87), e51222, doi:10.3791/51222 (2014).

Download .ris file

Copy

Share Video

.

Copy